Cargando…
Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens
The validation of candidate biomarkers often is hampered by the lack of a reliable means of assessing and comparing performance. We present here a reference set of serum and plasma samples to facilitate the validation of biomarkers for resectable pancreatic cancer. The reference set includes a large...
Autores principales: | Haab, Brian B., Huang, Ying, Balasenthil, Seetharaman, Partyka, Katie, Tang, Huiyuan, Anderson, Michelle, Allen, Peter, Sasson, Aaron, Zeh, Herbert, Kaul, Karen, Kletter, Doron, Ge, Shaokui, Bern, Marshall, Kwon, Richard, Blasutig, Ivan, Srivastava, Sudhir, Frazier, Marsha L., Sen, Subrata, Hollingsworth, Michael A., Rinaudo, Jo Ann, Killary, Ann M., Brand, Randall E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592020/ https://www.ncbi.nlm.nih.gov/pubmed/26431551 http://dx.doi.org/10.1371/journal.pone.0139049 |
Ejemplares similares
-
Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9
por: Tang, Huiyuan, et al.
Publicado: (2015) -
Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets
por: Chen, Jinyun, et al.
Publicado: (2016) -
The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer Cells
por: Barnett, Daniel, et al.
Publicado: (2017) -
Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers
por: Yue, Tingting, et al.
Publicado: (2011) -
Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer
por: Le, Uyen Q., et al.
Publicado: (2022)